Skip to the main content.
Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

Home > library Library

Veristat Resource Library

Safety, tolerability, and pharmacokinetics of a single orally inhaled dose of PUR3100, a dry powder formulation of dihydroergotamine versus intravenous dihydroergotamine: A Phase 1 randomized, double-blind study in healthy adults

Co-authored by Debora Manning, MPH, a Strategic Consulting Fellow and Biostatistician at Veristat, this research article presents the findings of a Phase 1 randomized, double-blind study targeting the acute treatment of migraines. The study evaluated the safety, tolerability, and systemic pharmacokinetics (PK) of a dry powder formulation of DHE when administered via inhalation versus intravenous delivery. For more insights, read the full article now.

download
Explore Our Key Related Services